Social Medical Progression of Coronary Heart Disease With Associated Psychosocial Comorbidity -Interval Rehabilitation.
- Conditions
- Cardiovascular Events
- Interventions
- Other: interval-rehabilitation
- Registration Number
- NCT01589536
- Lead Sponsor
- Clinic Roderbirken
- Brief Summary
The purpose of the study is to verfiy the hypothesis if a short intensive psychocardiological interval-intervention, combined with a structured follow up, decreases the rate of disability retirements caused by psychosocial co-morbidity of patients with coronary heart disease.
- Detailed Description
The purpose of the study is to verfiy the hypothesis if a short intensive psychocardiological interval intervention, combined with a structured follow up, decreases the rate of disability retirements caused by psychosocial co-morbidity of patients with coronary heart disease.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 480
- Coronary heart disease
- Disease-related psychosocial morbidity
- not a disability retirements
- Insured with the German Rheinland pension (deutsche Rentenversicherung Rheinland)
- Sufficient language skills
- Age 18-58
- Acute cardiac decompensation
- consuming the underlying disease
- psychotic disorder
- Acute suicidality
- pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Interventiongroup interval-rehabilitation A Stationary psychocardiological interval-rehabilitation.
- Primary Outcome Measures
Name Time Method Improvement of the social medical progression of coronary heart disease with associated psychosocial comorbidity by the use of interval rehabilitaion 24 months after including study Reducing the rate of disability pension of 18%of 9% by interval-rehabilitation with aftercare.
- Secondary Outcome Measures
Name Time Method Improvement of the social medical progression of coronary heart disease with associated psychosocial comorbidity by the use of interval rehabilitaion 24 months after including study Reduction of cardiovascular events, including deaths Improving the risk profile Improvement of health-related quality of life Improvement of mental comorbidity
Trial Locations
- Locations (1)
Clinic Roderbirken
🇩🇪Leichlingen, NRW, Germany